241 related articles for article (PubMed ID: 36581384)
1.
Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
[TBL] [Abstract][Full Text] [Related]
2. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
[TBL] [Abstract][Full Text] [Related]
3. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
4. Influence of MUC5B gene on antisynthetase syndrome.
López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
[TBL] [Abstract][Full Text] [Related]
5. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
McDermott G; Gill R; Gagne S; Byrne S; Huang W; Cui J; Prisco L; Zaccardelli A; Martin L; Kronzer VL; Moll M; Cho MH; Shadick N; Dellaripa PF; Doyle T; Sparks JA
Rheumatology (Oxford); 2022 Nov; 61(12):4915-4923. PubMed ID: 35289841
[TBL] [Abstract][Full Text] [Related]
6. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.
Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z
Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504
[TBL] [Abstract][Full Text] [Related]
7. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
[TBL] [Abstract][Full Text] [Related]
8. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Juge PA; Granger B; Debray MP; Ebstein E; Louis-Sidney F; Kedra J; Doyle TJ; Borie R; Constantin A; Combe B; Flipo RM; Mariette X; Vittecoq O; Saraux A; Carvajal-Alegria G; Sibilia J; Berenbaum F; Kannengiesser C; Boileau C; Sparks JA; Crestani B; Fautrel B; Dieudé P
Arthritis Rheumatol; 2022 Nov; 74(11):1755-1765. PubMed ID: 35583934
[TBL] [Abstract][Full Text] [Related]
9. Association of a
Higuchi T; Oka S; Furukawa H; Shimada K; Tsunoda S; Ito S; Okamoto A; Katayama M; Saisho K; Shinohara S; Matsui T; Migita K; Nagaoka S; Tohma S
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36717188
[TBL] [Abstract][Full Text] [Related]
10. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.
Wheeler AM; Baker JF; Poole JA; Ascherman DP; Yang Y; Kerr GS; Reimold A; Kunkel G; Cannon GW; Wysham KD; Singh N; Lazaro D; Monach P; Bridges SL; Mikuls TR; England BR
Semin Arthritis Rheum; 2022 Dec; 57():152098. PubMed ID: 36155967
[TBL] [Abstract][Full Text] [Related]
11.
Juge PA; Sparks JA; Gazal S; Ebstein E; Borie R; Debray MP; Kannengiesser C; McDermott GC; Cui J; Hayashi K; Doyle TJ; van Moorsel CHM; van der Vis JJ; Grutters JC; Knevel R; Heckert SL; Vasarmidi E; Antoniou KM; van der Helm van Mil AHM; Boileau C; Crestani B; Dieudé P
Rheumatol Adv Pract; 2024; 8(2):rkae059. PubMed ID: 38854416
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
13. Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
Zheng W; Hu X; Zou M; Hu N; Song W; Wang R; Liu Y; Hou Q; Liu Y; Chen X; Cheng Z
Inflammation; 2023 Feb; 46(1):285-296. PubMed ID: 36044099
[TBL] [Abstract][Full Text] [Related]
14. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
[TBL] [Abstract][Full Text] [Related]
15. Association of the
Shirai Y; Honda S; Ikari K; Kanai M; Takeda Y; Kamatani Y; Morisaki T; Tanaka E; Kumanogoh A; Harigai M; Okada Y
Ann Rheum Dis; 2020 Oct; 79(10):1305-1309. PubMed ID: 32737115
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the promoter
Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
Lee MG; Lee YH
Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Xie M; Zhu C; Ye Y
BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
[TBL] [Abstract][Full Text] [Related]
19. Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival.
Wilson TM; Solomon JJ; Humphries SM; Swigris JJ; Ahmed F; Wang H; Darrah E; Demoruelle MK
Am J Med Sci; 2023 Jun; 365(6):480-487. PubMed ID: 36918112
[TBL] [Abstract][Full Text] [Related]
20. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
Transpl Int; 2022; 35():10159. PubMed ID: 35651878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
